Arrowhead Research | ARWR - Devedores Comerciais

Preço das Ações
56.24
Mudança Diária
-0.47 -0.83%
Mensal
-11.56%
Anual
272.20%
Q1 Previsão
53.39




Devedores Comerciais Alterar Data
Agios Pharmaceuticals USD 10.58M 5.55M 2025-12
Alnylam Pharmaceuticals USD 777.57M 187.2M 2025-12
Anika Therapeutics USD 29.33M 661K 2025-12
Arrowhead Research USD 218.87M 212.05M 2025-12
Heron Therapeutics USD 89.59M 8.54M 2025-12
Incyte USD 1.02B 128.52M 2025-12
Ionis Pharmaceuticals USD 66M 41.39M 2025-12
Ligand Pharmaceuticals USD 58.1M 15.98M 2025-09
Merck USD 12.12B 596M 2025-09
Moderna USD 184M 862M 2025-12
Nektar Therapeutics USD 0 2.9M 2024-09
Novartis USD 8.98B 192M 2025-09
Sarepta Therapeutics USD 398.23M 2.49M 2025-12
TG Therapeutics USD 265.38M 33.86M 2025-09
Ultragenyx Pharmaceutical USD 112.54M 11.92M 2025-09
Vertex Pharmaceuticals USD 2.05B 106.4M 2025-12
Xencor USD 29.3M 7.49M 2025-12